microRNA Regulation of T Cell Senescence
T 细胞衰老的 microRNA 调控
基本信息
- 批准号:10318961
- 负责人:
- 金额:$ 53.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAntibodiesBCL6 geneBindingCD4 Positive T LymphocytesCell AgingCell CycleCell Differentiation processCellsCharacteristicsChromatinDUSP6 proteinDataDefectDevelopmentEnhancersFOXO1A geneFailureGene ExpressionGene Expression ProfileGene SilencingGenerationsGenesGenetic TranscriptionGlycolysis InhibitionGoalsHelper-Inducer T-LymphocyteHistonesHumanImmunologic MemoryImpairmentIn VitroIndividualInterventionMicroRNAsModern MedicineMoldsMusNucleosomesOlder PopulationPathway interactionsPatternPharmacologyPhosphoric Monoester HydrolasesProductionProliferatingProteomeProto-Oncogene Proteins c-aktReceptor ActivationReceptor SignalingRegulatory PathwaySIRT1 geneShapesSignal PathwaySignal TransductionStructureSupporting CellT cell differentiationT cell regulationT cell responseT memory cellT-Cell ActivationT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTestingTranscription Factor AP-1Transcriptional RegulationVaccinationWNT Signaling PathwayXCL1 geneYY1 Transcription Factorbasecellular transductiondesigneffector T cellimprovedin vivo Modelmemory CD4 T lymphocyteoverexpressionpreventpri-miRNAreconstitutiontranscription factortranscriptomevaccine response
项目摘要
PROJECT SUMMARY / ABSTRACT
Generation of protective vaccine responses, governed by the successful generation of T follicular helper cells
and long-lived memory T cells, is increasingly impaired with age. Since microRNAs are a major regulator of the
T cell proteome, we hypothesized that age-associated changes in the expression of microRNAs contribute to
the defects that are seen with T cell aging. MicroRNAs are known to concomitantly reduce expression of many
target molecules, frequently belonging to specific functional modules. While the effect on each of these
molecules is generally small, the concerted activity on signaling and transcription factor networks can have
major effects. MicroRNAs that are known to be are dynamically regulated during T cell differentiation include
miR-181a and miR-21. While miR-181a expression declines with T cell differentiation, miR-21 shows the
opposite pattern being higher in effector than in naïve CD4 T cells. For both miRNAs, naïve CD4 T cells from
older individuals reflect a state of higher differentiation with decrease in miR181a and increase in miR21
expression. miR-181a is known as a rheostat of T cell receptor signaling thresholds, and indeed older naïve T
cells are less responsive to stimulation due to the loss of miR-181a and the associated overexpression of dual
specific phosphatase 6. In preliminary studies, we have shown that miR-21 selects against T follicular helper
cell differentiation. The current proposal aims at identifying the pathways controlled by these microRNAs with
the ultimate goal to either target these microRNAs or the pathways that they regulate to improve immune
memory in older individuals after vaccination. In Aim 1, we propose to examine how the shift in miR-181a and
miR-21 expression with age selects against the development of transcriptional signatures characteristic of T
follicular helper cells and T memory cells. Specifically, we will examine how these microRNAs influence
transcription factor networks including FOXO, AP1, BLIMP, BCL6 and TCF1 that are important for T follicular
helper and T memory cell differentiation. In Aim 2, we examine consequences of reduced miR-181a
expression on the transcription of histone genes and determine the consequences of reduced histones on the
nucleosome organization of effector and memory T cells and their ability to proliferate and survive. Aim 3 will
examine whether transcription of pri-miR-21 and/or pri-miR-181a can be targeted to improve T cell responses.
Based on preliminary studies on transcriptional regulation of these pri-miRNAs, activation of WNT signaling
and inhibition of AP1 activity emerge as candidate interventions to restore miR-181a1 and reduce miR-21
expression.
项目总结/摘要
产生保护性疫苗反应,由T滤泡辅助细胞的成功产生控制
和长寿的记忆T细胞,随着年龄的增长越来越受损。由于microRNA是一种主要的调节因子,
T细胞蛋白质组,我们假设与年龄相关的microRNA表达的变化有助于
T细胞老化的缺陷。已知微小RNA伴随着减少许多基因的表达。
靶分子,通常属于特定的功能模块。虽然对每一个人的影响
分子通常很小,信号传导和转录因子网络上的协同活动可以具有
重大影响。已知在T细胞分化过程中动态调节的microRNA包括
miR-181 a和miR-21。虽然miR-181 a的表达随着T细胞分化而下降,但miR-21显示了T细胞分化的抑制作用。
相反的模式在效应细胞中比在幼稚的CD 4 T细胞中更高。对于这两种miRNAs,来自
老年个体反映了较高的分化状态,miR 181 a减少,miR 21增加
表情miR-181 a被认为是T细胞受体信号阈值的变阻器,事实上,
由于miR-181 a的缺失和相关的双重miR-181 a的过度表达,细胞对刺激的反应性降低。
特异性磷酸酶6。在初步研究中,我们已经表明miR-21选择性地对抗T滤泡辅助细胞,
细胞分化目前的建议旨在确定这些microRNA控制的途径,
最终目标是靶向这些microRNA或它们调节的途径,
老年人接种疫苗后的记忆力。在目标1中,我们建议研究miR-181 a和miR-181 b的变化如何影响miR-181 a和miR-181 b的表达。
miR-21的表达与年龄的选择对T细胞特征性转录特征的发展
滤泡辅助细胞和T记忆细胞。具体来说,我们将研究这些microRNA如何影响
转录因子网络,包括FOXO、AP 1、BLIMP、BCL 6和TCF 1,它们对T细胞滤泡
辅助细胞和T记忆细胞分化。在目标2中,我们研究了减少miR-181 a的后果,
表达对组蛋白基因转录的影响,并确定减少组蛋白对细胞增殖的影响。
效应和记忆T细胞的核小体组织及其增殖和存活的能力。目标3将
检查pri-miR-21和/或pri-miR-181 a的转录是否可以靶向改善T细胞应答。
基于对这些pri-miRNAs转录调控的初步研究,WNT信号的激活
和抑制AP 1活性成为恢复miR-181 a1和减少miR-21的候选干预措施
表情
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JORG J GORONZY其他文献
JORG J GORONZY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JORG J GORONZY', 18)}}的其他基金
Memory T cell development and survival in T cell responses of older individuals
老年人 T 细胞反应中记忆 T 细胞的发育和存活
- 批准号:
9331942 - 财政年份:2017
- 资助金额:
$ 53.72万 - 项目类别:
Memory T cell development and survival in T cell responses of older individuals
老年人 T 细胞反应中记忆 T 细胞的发育和存活
- 批准号:
9904524 - 财政年份:2017
- 资助金额:
$ 53.72万 - 项目类别:
Memory T Cell Development and Survival in T Cell Responses of Older Individuals
老年个体 T 细胞反应中记忆 T 细胞的发育和存活
- 批准号:
10430906 - 财政年份:2017
- 资助金额:
$ 53.72万 - 项目类别:
microRNA Regulation of T Cell Senescence
T 细胞衰老的 microRNA 调控
- 批准号:
10435599 - 财政年份:2014
- 资助金额:
$ 53.72万 - 项目类别:
microRNA Regulation of T Cell Senescence
T 细胞衰老的 microRNA 调控
- 批准号:
10552542 - 财政年份:2014
- 资助金额:
$ 53.72万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 53.72万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 53.72万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 53.72万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 53.72万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 53.72万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 53.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 53.72万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 53.72万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 53.72万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 53.72万 - 项目类别: